Nasdaq Bear Market: 3 Jaw-Dropping Growth Stocks You'll Regret Not Buying on the DipThe Motley Fool • 05/07/22
Novavax Guides To At Least $4 Billion In 2022 Sales — Is It A Buy Now?Investors Business Daily • 05/06/22
Novavax (NVAX) Surges 19.3%: Is This an Indication of Further Gains?Zacks Investment Research • 05/03/22
Novavax (NVAX) to Report Q1 Results: Wall Street Expects Earnings GrowthZacks Investment Research • 05/02/22
Novavax to Host Conference Call to Discuss First Quarter 2022 Financial Results and Operational Highlights on May 9, 2022PRNewsWire • 05/02/22
FDA Sets Review Dates For Pfizer, Moderna COVID-19 Shot For Kids, Plus Novavax EUABenzinga • 04/29/22
FDA panel to discuss Novavax Covid vaccine for adults, Pfizer and Moderna shots for kids in JuneCNBC • 04/29/22
FDA Announces Vaccines and Related Biological Products Advisory Committee Review of Novavax' COVID-19 VaccinePRNewsWire • 04/29/22